HIGHLIGHTS
- who: Victoria Platte and colleagues from the Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine-University, Duesseldorf, Germany have published the research: Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component, in the Journal: (JOURNAL)
- what: For the purpose of this analysis, patients were divided into those with either early (u226412 months after allo-SCT) and late relapses (any timepoint of relapse >12 months after allo-SCT), according to a commonly chosen interval .
SUMMARY
While several reports . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.